Nov 04,2021

Pediatric Endocrinology Clinic At University Of Florida Expands Implementation Of DreaMed Technology

The clinic will begin using the Advisor Pro Decision-Support System for Type 2 Diabetes, which has recently received FDA clearance, enhancing the clinic’s offering to health care practitioners and patients.

PRODUCT

#dtx

#rpm

View Analyst & Ambassador Comments
Go to original news
Nov 10,2021

Signos raises $13M Series A to give you real-time weight-loss advice based on your blood glucose levels

Weight-loss startup Signos is betting that you’re curious enough about the difference between our respective metabolisms to sign up for real-time glucose monitoring and alerts to keep you in shape. It turns out that GV believes that, too, to the tune of leading the company’s $13 million Series A round.

FUNDING SERIES A

#cgm

View Analyst & Ambassador Comments
Go to original news
Nov 15,2021

DarioHealth Appoints Seasoned Health Care Executive Jerrod Helms as Chief Commercial Officer

DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics market, today announced that the Company appointed Jerrod Helms to the newly created role of Chief Commercial Officer (CCO) to support the rapid expansion of business in the employer, payer, provider and partnership markets that the company has seen over the last quarter and the anticipated acceleration into 2022. Mr. Helms will report to Rick Anderson, President and General Manager North America.

View Analyst & Ambassador Comments
Go to original news
Nov 17,2021

Terumo Corporation and Diabeloop SA. Enter into Comprehensive Strategic Partnership Agreement to Expand Their Diabetes Care Offerings

Terumo Corporation, a global leader in medical technology and the French company Diabeloop, a pioneer in therapeutic AI, announced today that they have signed an agreement for a comprehensive strategic partnership. With this agreement, in addition to the current joint development of the AID system for Japan, they will work closely to bring Automated Insulin Delivery solutions to Europe with potential further global expansion.

COLLABORATION PARTNERSHIP

#r&d

#closed loop

View Analyst & Ambassador Comments
Go to original news
Nov 17,2021

Vitality partners with my mhealth to provide their members with cutting edge digital therapeutics

A new partnership between Vitality and Bournemouth-based digital healthcare pioneer my mhealth offers Vitality members access to an entire suite of cutting-edge digital therapeutics designed to manage long-term health conditions. Vitality members will receive 50% discount on annual subscription to any of the my mhealth apps: myCOPD, myDiabetes, myHeart, myAsthma and, myOp. 

COLLABORATION PARTNERSHIP

#insurance

#dtx

#mobile app

View Analyst & Ambassador Comments
Go to original news
Nov 17,2021

Health2Sync to Launch Asia's First Data Integration of Health Management App and CGM Data

Taiwan-based diabetes management app Health2Sync has launched the latest version of its mobile app for about 200,000 users in Japan that now integrates continuous glucose monitoring data from the Abbott FreeStyle LibreLink mobile app.

PRODUCT

#cgm

#dtx

View Analyst & Ambassador Comments
Go to original news
Nov 18,2021

Tandem Diabetes Care to Participate in the 33rd Annual Piper Sandler Virtual Healthcare Conference

Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, is scheduled to participate in the 33rd Annual Piper Sandler Virtual Healthcare Conference on December 2, 2021.

CONFERENCES
View Analyst & Ambassador Comments
Go to original news
Nov 18,2021

DarioHealth Announces Two New Employer Contracts

DarioHealth Corp. (Nasdaq: DRIO), a leader in the global digital therapeutics (DTx) market, announced today that it has contracted with two employers to provide its highly personalized digital therapeutic beginning in the first quarter of 2022. The new clients include a national transportation employer contracted for diabetes, and a regional employer contract for behavioral health. The two new contracts bring Dario's total signed clients to date to 49 as interest in the employer market demand intensifies across the full suite of solutions.

View Analyst & Ambassador Comments
Go to original news
Nov 20,2021

How Frequently and for How Long Do Adults With Type 2 Diabetes Use Management Apps? The REALL Study

The objective of the study is to identify predictors of utilization of a type 2 diabetes (T2D) management App over time for insulin users (IUs) and noninsulin users (NIUs).

CLINICAL STUDY

#mobile app

View Analyst & Ambassador Comments
Go to original news
Nov 22,2021

Effects of Alternate Insulin Pump Settings in Patients With Type 1 Diabetes During Ramadan: A Randomized Pilot Study

Various studies have evaluated the safety and efficacy of using insulin pumps during Ramadan; some of them demonstrated favorable outcomes in reducing hypoglycemia and hyperglycemia. However, there is no consensus on the recommendations for basal insulin adjustments and the utilization of technical features of insulin pumps to improve glycemic control.

CLINICAL STUDY

#cgm

#insulin pump

View Analyst & Ambassador Comments
Go to original news
Subscribe to DIABETES